Skip to main content

Kuniko Nishikawa

Analytics firm Fronteo Healthcare has chosen Kuniko Nishikawa as its new CEO. Nishikawa had been an independent director of the healthcare subsidiary of Tokyo-based Fronteo Inc. since December. She replaces previous CEO Naritomo Ikeue, who has agreed to remain on the board of directors, overseeing business development for Fronteo Healthcare. The company also named Masahiro Morimoto executive chairman. 

The Scan

Possibly as Transmissible

Officials in the UK say the B.1.617.2 variant of SARS-CoV-2 may be as transmitted as easily as the B.1.1.7 variant that was identified in the UK, New Scientist reports.

Gene Therapy for SCID 'Encouraging'

The Associated Press reports that a gene therapy appears to be effective in treating severe combined immunodeficiency syndrome.

To Watch the Variants

Scientists told US lawmakers that SARS-CoV-2 variants need to be better monitored, the New York Times reports.

Nature Papers Present Nautilus Genome, Tool to Analyze Single-Cell Data, More

In Nature this week: nautilus genome gives peek into its evolution, computational tool to analyze single-cell ATAC-seq data, and more.